AbbVie, Inc.(NYSE : ABBV)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading ABBV News...
Health Technology » Pharmaceuticals Major
|MRK||Merck & Co., Inc.||3.65%||62.53||0.6%||$770.31m|
|JNJ||Johnson & Johnson||-0.04%||114.15||0.7%||$598.50m|
|BMY||Bristol-Myers Squibb Company||-11.29%||49.23||0.7%||$554.17m|
|LLY||Eli Lilly and Company||-0.05%||76.80||1.0%||$325.59m|
|NVS||Novartis AG Sponsored ADR||0.31%||70.65||0.2%||$244.73m|
|AZN||AstraZeneca PLC Sponsored ADR||-3.01%||27.07||1.0%||$157.50m|
|GSK||GlaxoSmithKline plc Sponsored ADR||-0.08%||38.72||0.2%||$127.25m|
|SNY||Sanofi Sponsored ADR||0.55%||40.39||0.1%||$83.32m|
|NVO||Novo Nordisk A/S Sponsored ADR Class B||-0.25%||35.54||0.2%||$75.96m|
|LCI||Lannett Company, Inc.||0.65%||19.33||30.2%||$21.40m|
|SCMP||Sucampo Pharmaceuticals, Inc. Class A||-0.44%||11.40||15.0%||$13.03m|
|AKTX||Akari Therapeutics Plc Sponsored ADR||-6.63%||7.47||0.1%||$0.02m|
|EPIX||ESSA Pharma Inc||0.00%||2.02||0.0%||$0.01m|
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.